Back

Telomere length in patients with adult congenital heart disease

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease and pulmonary hypertension: diagnosis and management Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tijs Tournoy

University Hospital Ghent, Gent (Belgium)

5 More presentations in this session

Presentation thumbnail
ECG-based artificial intelligence for risk stratification and outcome prediction after shunt closure in congenital heart disease
Mr D. Ahmetagic (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Phenotyping of pulmonary arterial hypertension associated with congenital heart disease using latent class analysis: insights from a national prospective registry
Doctor Q. Li (Beijing, CN)
Abstract Slides
Presentation thumbnail
Syndromic conditions in adults with congenital heart disease: prevalence, recognition and clinical impact
Doctor M. Umei (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Cerebrovascular disease in adults with aortic coarctation
Doctor K. Goto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Mental health burden and health-related quality of life in adults with congenital heart disease: a cross-sectional study
Doctor A. Martin Garcia (Salamanca, ES)
Abstract Slides

Access the full session

Session thumbnail
Adult congenital heart disease and pulmonary hypertension: diagnosis and management

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter?
13 April 2024
thumbnail
Congress Session
Congenital heart disease throughout life
23 June 2023
thumbnail
Congress Presentation
Acute myeloid leukemia with KMT2A rearrangements in children with congenital heart disease: case series and literature review
21 June 2025
thumbnail
Congress Presentation
Sexual functioning after the age of 40 in adults with moderate or severe congenital heart disease
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources